Table 5.
Alternative treatment options for patients with advanced unresectable HCC after tumor progression.
| Treatment options | n=11 |
|---|---|
| Replacement targeted agents | |
| Regorafenib | 3 |
| Apatinib | 4 |
| Attilizumab + bevacizumab | 2 |
| Add other local treatment | |
| TACE | 8 |
| Cyberknife | 2 |
HCC, hepatocellular carcinoma; TACE, transcatheter arterial chemoembolization.